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The scaffold protein Ste5 is required to properly
direct signaling through the yeast mating pathway
to the mitogen-activated protein kinase (MAPK),
Fus3. Scaffolds are thought to function by tethering
kinase and substrate in proximity. We find, however,
that the previously identified Fus3-binding site on
Ste5 is not required for signaling, suggesting an alter-
native mechanism controls Fus3’s activation by the
MAPKK Ste7. Reconstituting MAPK signaling
in vitro, we find that Fus3 is an intrinsically poor
substrate for Ste7, although the related filamentation
MAPK, Kss1, is an excellent substrate. We identify
and structurally characterize a domain in Ste5 that
catalytically unlocks Fus3 for phosphorylation by
Ste7. This domain selectively increases the kcat of
Ste7/Fus3 phosphorylation but has no effect on
Ste7/Kss1 phosphorylation. The dual requirement
for both Ste7 and this Ste5 domain in Fus3 activation
explains why Fus3 is selectively activated by the
mating pathway and not by other pathways that
also utilize Ste7.
INTRODUCTION
Living cells receive vast amounts of environmental information,
and a central question is how the cell’s system of signal trans-
duction proteins is able to specifically process this information.
This problem is particularly acute given that many closely related
molecules (e.g., kinases, phosphatases, etc.) are involved in
diverse, functionally distinct signaling pathways. An emerging
paradigm is that, in many cases, signaling pathways are orga-
nized by scaffold proteins. Scaffolds are proteins that interact
with multiple members of a pathway and are thought to function
as ‘‘wiring’’ elements that by tethering pathway components intocomplexes and localizing them to specific sites in the cell, direct
the flow of signaling information. Scaffolds are proposed to both
enhance interactions between the correct signaling proteins and
to insulate them from interactions with competing proteins
(Bhattacharyya et al., 2006a, 2006b; Burack et al., 2002; Burack
and Shaw, 2000).
One of the first identified examples of a signaling scaffold is the
Ste5 protein from Saccharomyces cerevisiae, which plays an
essential role in signal transmission through the yeast mating
pathway. When yeast are stimulated by mating pheromone
from the opposite mating type, signal is transmitted from the
mating receptor (Ste2) via a heterotrimeric G protein (Gpa1,
Ste4 and Ste18) to a mitogen-activated protein (MAP) kinase
cascade. MAP kinase cascades are composed of three kinases
that successively phosphorylate and activate one another: signal
passes from a MAP kinase kinase kinase (MAPKKK) to a MAP
kinase kinase (MAPKK) and finally to a MAP kinase (MAPK). In
the mating pathway, signal is transmitted from the MAPKKK
Ste11 to the MAPKK Ste7 to the MAPK Fus3. The Ste5 scaffold,
although it has no catalytic domains (e.g., kinase domains), is
required for the mating response. Ste5 was initially identified
as a scaffold protein because, by yeast two-hybrid assays, it
was shown to have binding sites for all three MAPK cascade
members (Ste11, Ste7, and Fus3) (Choi et al., 1994) and the
Gb protein, Ste4 (Whiteway et al., 1995). Interaction with Ste4
localizes the Ste5 complex to the membrane upon stimulation,
allowing Ste11 to be activated by a membrane-localized (PAK)
kinase, Ste20. Additionally, interaction of Ste5 with the kinases
in the cascade is thought to promote their successive phosphor-
ylation.
The need for robust mechanisms for controlling signaling
specificity is particularly important for the mating pathway
because of the potential for cross-signaling with other related
MAPK pathways that use overlapping signaling components.
For example, the filamentous growth pathway, which is activated
by nitrogen starvation, requires kinases shared with the mating
pathway: the MAPKKK Ste11 and the MAPKK Ste7 (although it
does not require the scaffold Ste5). During the mating response,Cell 136, 1085–1097, March 20, 2009 ª2009 Elsevier Inc. 1085
A B C
Figure 1. Ste5 Scaffold Protein Is Required for Mating Pathway Signaling
(A) The MAPKKK Ste11 and MAPKK Ste7 function in both the mating and filamentation pathways in yeast. Ste7 must select the appropriate MAPK to phosphor-
ylate in response to input (Fus3 for a-factor, and Kss1 for starvation).
(B) During mating, stimulation with a-factor leads primarily to phosphorylation of Fus3. This reaction requires the scaffold protein Ste5. Starvation input specif-
ically induces the filamentation response through phosphorylation of Kss1. The Ste5 scaffold is not required for filamentation.
(C) Expression of a constitutively active allele of MAPKKK Ste11 in a strain lacking Ste5 results only in Kss1 phosphorylation (both Kss1 and Fus3 phosphorylation
are observed in strains with Ste5), further indicating that the Ste5 scaffold is required, in vivo, for Ste11/Ste7/Fus3 signaling (Flatauer et al., 2005).signaling to Ste7 is primarily transmitted to the MAPK Fus3, while
in the filamentation pathway signaling is transmitted to the MAPK
Kss1. Here we focus on the critical question of how activated
Ste7 chooses between the two MAP kinases, Fus3 and Kss1,
which are 55% identical (Figure 1A). Why does Ste7 that is acti-
vated by pheromone stimulation phosphorylate Fus3, whereas
Ste7 that is activated by nitrogen starvation phosphorylate only
Kss1? What is the role of the Ste5 scaffold in this specificity
choice?
Despite the importance of Ste5 as a canonical example of
a scaffold protein, little is understood about the biochemical
mechanisms that scaffolds use to regulate MAPK signaling
specificity. The simplest model for how a scaffold might promote
phosphorylation of one substrate versus another is through teth-
ering – by increasing the proximity and effective concentration of
components in the scaffold complex. Tethering, appears to be
important for certain key aspects of Ste5 function: mutation of
the binding sites for the Ste11 and Ste7 kinases disrupts signal
transmission, while re-recruitment of these proteins to the Ste5
complex via heterologous engineered protein-protein interac-
tions or covalent fusion can partially rescue signaling (Harris
et al., 2001; Park et al., 2003).
The mechanism by which Ste5 directs signaling from the
MAPKK Ste7 to the MAPK Fus3, however, is far less clear. Is
the scaffold needed to colocalize these kinases or does it play
some other role? Previous work identified and characterized
a binding site for Fus3 within Ste5. This 30 amino acid peptide
(288–316) binds Fus3 with an affinity of 1 mM, and it stimulates
partial Fus3 autophosphorylation (it promotes one of two phos-
phorylation events required for Fus3 activation) (Bhattacharyya
et al., 2006a). Surprisingly, however, mutation of this Fus3
binding site does not block mating but actually increases mating
output (as measured by transcription), suggesting that this site
plays more of a tuning role, modulating signaling dynamics
(Bhattacharyya et al., 2006a). Nonetheless, the scaffold as
a whole is still absolutely required for signaling to Fus3. Thus, it1086 Cell 136, 1085–1097, March 20, 2009 ª2009 Elsevier Inc.appears that there may be another site in Ste5 that controls
Fus3 activation and that the scaffold may be playing a more
active or catalytic role in controlling signal transmission to this
MAP kinase.
Here we have purified components of the mating and filamen-
tous growth MAP kinase pathways (Ste7, Fus3, Kss1, and Ste5)
in order to understand the role of scaffolds in specifying in
MAPKK/MAPK signal transmission. We find that Fus3 is intrin-
sically a poor substrate for activated Ste7, while Kss1 is intrinsi-
cally a very good substrate. A 200 residue segment of Ste5,
however, is sufficient to permit Ste7 phosphorylation of Fus3
but has no effect on Kss1 phosphorylation. This Ste5 fragment
is distinct from the previously identified Fus3 binding site, and
crystallographic studies show that it is an independently folding
domain which we refer to as Ste5-ms (minimal scaffold). The
Ste5-ms domain binds tightly to Ste7, but only very weakly to
Fus3. However, mutational and kinetic studies show that the
Ste5-ms fragment can catalytically unlock the Fus3 MAPK so
that it is now a good substrate for Ste7. This domain specifically
increases the kcat for the Ste7/ Fus3 reaction by 5000-fold,
while it has no effect on the kcat or KM of the Ste7/ Kss1 reac-
tion. Fus3 appears to have evolved a structure that is ‘‘locked’’ to
prevent stray activation by isolated forms of Ste7 (generated by
non-mating inputs). Phosphorylation of Fus3 occurs only in the
combined presence of Ste7 and Ste5, and this mechanism
explains why Fus3 is only activated by mating input.
RESULTS
Fus3 Is an Intrinsically Poor Substrate for Ste7
that Requires Ste5 as a Coactivator
The MAPKK, Ste7, is used in two distinct yeast MAPK pathways,
the mating and filamentous growth pathways. When stimulated
by a-factor (pheromone input for the mating pathway), Ste7
primarily activates the mating-specific MAPK Fus3. However,
when stimulated by starvation (input for the filamentation or
Figure 2. Fus3 Is Intrinsically a Poor Substrate for Ste7, Unless the Ste5 Scaffold Is Present
(A) Fus3 and Kss1 both bind tightly to docking motifs (D-motifs) on Ste7 (KD 100nM for each MAPK).
(B) Coomassie stained gel showing purified components of the mating and filamentation MAPK pathways.
(C and D) Activation of Kss1 and Fus3 by Ste7EE in vitro measured using the Trulight kinase assay - in which phosphorylation of a MAPK-specific labeled peptide
substrate results in a decrease in fluorescence over time (the peptide quenches signal of a sensor bead coated with fluorescent polymers) (see Figures S2A–S2C).
50 nM of each protein was used in these assays. Ste7EE rapidly activates Kss1, and addition of the Ste5 scaffold has no impact on the reaction. (D) Fus3 cannot
be activated by Ste7EE, unless DN-Ste5 is added. These results demonstrate that Fus3 is intrinsically a very poor substrate for Ste7, and that Ste5 is a required
coactivator in Ste7/Fus3 phosphorylation.haploid invasive growth pathway), Ste7 activates Kss1. How
Ste7 makes the appropriate input-dependent substrate choice
between Fus3 and Kss1 (Figure 1A) is a challenging question,
as the two alternative MAP kinases are very closely related
(55% identity; > 70% similarity; Figure S8A available online).
Previous genetic work indicates that the Ste5 scaffold is required
to direct signal from a constitutively active MAPKKK Ste11
through Ste7 to the mating MAPK Fus3 (Figure 1C) (Flatauer
et al., 2005). Could Ste5 be playing a direct role in the selective
activation of Fus3 by Ste7? To investigate the biochemical
requirements for Ste7/MAPK specificity, we purified key
components and reconstituted this pathway step in vitro.
Previous studies have shown that in addition to any scaffold
(Ste5) contributions, Ste7/Fus3 phosphorylation requires direct
docking interactions between the two proteins (Figure 2A). Ste7
has two MAPK docking motifs on its N-terminus. These are 10
residue peptide motifs (consensus motif: [RK][RK]X(4-6)LxL) that
are found to mediate functional interactions between MAPKs
and a variety of their regulators and substrates (Remenyi et al.,
2006). At least one of these docking motifs is required for phos-
phorylation of either Fus3 or Kss1 by Ste7 (Bhattacharyya et al.,
2006a; Remenyi et al., 2005). However, the docking sites in Ste7
cannot be sufficient to distinguish between Fus3 and Kss1, since
they bind to both Fus3 and Kss1 with roughly equal affinity
(stronger site KD 100nM) (Remenyi et al., 2005).We first investigated whether Ste7 could activate the MAPKs
Fus3 and Kss1 in vitro. We expressed and purified the following
recombinant proteins: Fus3, Kss1, a constitutively active form of
Ste7 (Ste7EE, bearing S359E and T363E phosphomimic muta-
tions in the Ste7 activation loop) (Maleri et al., 2004), and
DN-Ste5 (Ste5, with a 279 residue N-terminal deletion, which
makes the protein soluble and biochemically tractable)
(Figure 2B). The ability of Ste7EE to activate Fus3 or Kss1 was
measured using a fluorescence-based MAPK assay (Trulight
kinase assay, Calbiochem–see Figure S2). We found that Ste7EE
rapidly activated Kss1, either in the presence or absence of puri-
fied Ste5 (all components at 50 nM) (Figure 2C). In contrast,
Ste7EE cannot activate Fus3, demonstrating that Fus3 is an
intrinsically weak substrate for Ste7 (Figure 2D). If, however,
the Ste5 scaffold is added, Ste7 rapidly phosphorylates Fus3
at a rate comparable to Kss1 (Figure 2D). These results indicate
that Fus3 is inherently a poor substrate for Ste7, but that Ste5
can serve as a coactivator to permit efficient Ste7/Fus3 phos-
phorylation.
A Novel Domain in Ste5 Is Required
for Fus3 Phosphorylation by Ste7
How does the Ste5 scaffold permit Ste7/Fus3 phosphoryla-
tion? The simplest model is that a protein scaffold like Ste5
acts as a tethering or colocalization device that enhances theCell 136, 1085–1097, March 20, 2009 ª2009 Elsevier Inc. 1087
A C
D
E
B
F G
Figure 3. Ste5 Contains a Novel Domain Required for Ste7/Fus3 Phosphorylation
(A) Ste5 is a large protein (917 aa) that contains previously identified binding sites for the mating pathway kinases. Canonical tethering model proposes that Ste5
colocalizes three kinases in the mating pathway (Ste11, Ste7, Fus3) to promote signaling.
(B) Deletion mapping identifies minimal region of Ste5 required for Ste7EE/Fus3 phosphorylation in vitro. As in Figure 2, Trulight assay was used to measure
Fus3 activation by Ste7EE. Amino acids 593–786 of Ste5 define the ‘‘minimal scaffold’’ domain (Ste5-ms) sufficient to promote Ste7/Fus3 phosphorylation.
(C) Confirmation that the Fus3-binding region (KD = 1 mM) in Ste5 is not required for phosphorylation of Fus3 by Ste7EE. DN-Ste5-ND (green curve) is a variant of
DN-Ste5 (black curve) bearing a mutation in the Fus3 binding region that disrupts interaction with Fus3. For panels C-E all reaction components are at 50 nM.
(D) Ste5-ms domain is as active as the larger scaffold protein (DN-Ste5).
(E) MAPK docking motifs on Ste7EE (KD 100 nM) are necessary for Fus3 activation. Mutation of these sites disrupt Ste7/ Fus3 phosphorylation, even in the
presence of Ste5 (purple curve).
(F) Ste5-ms binds to Ste7 but not to Fus3. Interactions were measured with fluorescence polarization (anisotropy) using 5nM of fluoroscein-labeled Ste5-ms. Error
bars represent standard deviation of three sets.
(G) Minimal interactions necessary for formation of the Ste5-Ste7-Fus3 signaling complex.interaction of proteins that interact poorly on their own
(Figure 3A). Consistent with a tethering model, mutagenesis of
Ste5 and a prior yeast-two hybrid study have identified binding1088 Cell 136, 1085–1097, March 20, 2009 ª2009 Elsevier Inc.sites for both Ste7 and Fus3 within the Ste5 scaffold (Choi
et al., 1994; Inouye et al., 1997a; Figure 3B). Conversely, two
other results argue strongly that Ste5 is not acting as a simple
tether to promote Ste7/Fus3 phosphorylation. First, as
described above, Fus3 can already bind tightly to Ste7 without
the scaffold due to the MAPK docking motifs found at the
N-terminus of Ste7 (Bardwell et al., 1996; Remenyi et al., 2005).
Second, we show here that the previously identified Fus3 binding
site in Ste5 (residues 288–316 in Ste5) is not required to promote
the Ste7/Fus3 reaction. A variant of Ste5, in which this site is
mutated so that it no longer binds Fus3 (Ste5-ND) (Bhattacharyya
et al., 2006a), is indistinguishable from the wild-type protein in its
ability to promote the Ste7/Fus3 reaction in vitro (Figures 3B
and 3C). In contrast when the MAPK docking sites in Ste7 are
mutated, Ste7 cannot phosphorylate either Fus3 or Kss1, both
in the presence or absence of Ste5 (Figure 3E). Furthermore,
when the previously identified Fus3 binding domain in Ste5 is
mutated in vivo, mating output upon alpha-factor stimulation
actually increases (Bhattacharyya et al., 2006a). Together, these
results are consistent with a model in which this previously char-
acterized Fus3 binding motif does not play a role in promoting the
main flow of signaling information from the MAPKK Ste7 to the
MAPK Fus3, but rather plays a modulatory role in tuning the quan-
titative and dynamic output of the pathway.
The finding that the Fus3 binding domain in Ste5 is not
required for mating signaling in vitro led us to postulate that there
might be a different region of Ste5 that promotes Ste7/Fus3
phosphorylation. Therefore, we performed deletion analysis to
search for the minimal region of Ste5 that was capable of permit-
ting Ste7/Fus3 phosphorylation (Figure 3B). We identified a
200 residue fragment of Ste5 (593-786) that was sufficient for
promoting Fus3 phosphorylation. As will be discussed later,
structural analysis revealed that this fragment forms a unique,
independently folded domain. This domain was at least as active
as a larger fragment of Ste5 (DN-Ste5) in promoting Ste7/Fus3
phosphorylation (Figure 3D) and we refer to the domain as the
Ste5 minimal scaffold (Ste5-ms). The Ste5-ms domain lacks
the previously identified Fus3 and Ste11-binding regions but
contains part of the previously mapped Ste7-binding region
(Inouye et al., 1997a).
In fluorescence polarization binding studies, we found that the
Ste5-ms domain binds tightly to Ste7 (KD = 75nM) (Figure 3F) but
does not detectably bind to Fus3 (Figure 3F). The lack of a strong
Fus3 binding site in the Ste5-ms fragment argues against
a mechanism in which this fragment is acting as a passive tether,
simply increasing the effective concentration of Ste7 and Fus3.
Although colocalization of the two proteins does appear to be
necessary, it is the direct docking interaction between the
MAPKK Ste7 and MAPK Fus3 that plays this role (Figure 3G).
Tethering of the two proteins (Ste7 and Fus3) together, however,
does not seem to be sufficient for Fus3 activation. Thus the Ste5-
ms domain must play a distinct functional role in promoting
phosphorylation.
Ste5-ms Selectively Improves kcat for Fus3
but Not Other Substrates
To understand precisely how the Ste5-ms domain contributes to
Fus3 phosphorylation we performed quantitative kinetic anal-
yses (Figure 4). We measured the kcat and KM of Fus3 and
Kss1 phosphorylation by Ste7EE both in the presence and
absence of the Ste5-ms fragment (scaffold concentration1 mM). To simplify the kinetic analysis, we used a variant of
Ste7 with a single docking site (mutant Ste7EE-ND2 has the
second, weaker docking motif removed). This Ste7EE variant
has the same kcat as Ste7EE with both docking motifs, and
behaves similarly in other assays both in vivo (Bhattacharyya
et al., 2006a) and in vitro (data not shown) (Remenyi et al.,
2005). As a substrate, we used a catalytically-dead allele of the
MAPK Fus3 (K42R) in order to eliminate background autophos-
phorylation that is observed for the wild-type protein.
These experiments show that the Ste5-ms domain enhances
the kcat of Fus3 phosphorylation by Ste7EE by 5000-fold,
with little effect on the KM (Figure 4C), further contradicting
a potential tethering role for the Ste5-ms domain (which would
be expected to lower the KM). This effect on kcat is highly
substrate specific - the Ste5-ms domain has essentially no
impact, positive or negative, on the kcat or KM of Kss1 phosphor-
ylation by Ste7 (Figures 4C and 4D). By varying the concentration
of Ste5-ms in a reaction containing 50 nM Ste7EE-ND2 and satu-
rating (750 nM) Fus3 we determined that the concentration of
Ste5-ms required to maximally exert its effects is less than
1 mM. This titration experiment gives a midpoint of activation
(Kactivation, an estimation of Ste7/Ste5-ms dissociation) of
161 nM. This number is roughly the same as the KD for the
Ste7-Ste5-ms interaction measured by anisotropy (75 nM),
consistent with a model in which the Ste7/Ste5-ms complex is
the catalytically competent complex.
A simple model for how the Ste5-ms domain kinetically modu-
lates the Fus3 phosphorylation reaction is shown in the reaction
coordinate free energy diagrams (Figure 4F). Ste7EE is able to
phosphorylate Kss1 efficiently in the presence or absence of
Ste5 because it has a low transition state energy (EdS z). In
contrast, Ste7EE is unable to phosphorylate Fus3, because it
has a much higher transition state energy—Fus3 is an intrinsi-
cally poor substrate. The Ste5-ms scaffold domain is able to
lower the energy of Fus3’s transition state, resulting in a higher
kcat, thereby converting a very poor substrate into a good
substrate, comparable to Kss1. Thus, the Ste5-ms domain is
essentially serving as a substrate specific cocatalyst for
Ste7/Fus3 phosphorylation – a role that is conceptually similar
to that of a cyclin which acts as a cocatalyst for the cyclin-depen-
dent kinase (Cdk).
Ste5-ms Is a Folded Domain with Distinct Surfaces
for Communicating with Ste7 and Fus3
To understand how the Ste5-ms domain might act as
a substrate-specific cocatalyst, we determined the structure of
the domain. We obtained crystals of the Ste5-ms fragment and
solved the structure to 1.6 A˚ resolution (Figures 5A and S5A
and Table S2; PDB ID = 3FZE). This fragment adopts a well-
ordered, independently folded structural domain. While primary
sequence analysis (BLAST) failed to identify proteins clearly
related to the Ste5-ms domain (outside of yeasts closely related
to S. cerevisiae), the structural homology program DALI (Holm
and Sander, 1996) showed that this domain shares the same
fold as the von-Willebrand Type-A (VWA) domain found in extra-
cellular matrix proteins and integrin receptors (Figures 5B and
S5B). Although many of known VWA domain proteins are extra-
cellular, the most ancient VWA domains conserved across allCell 136, 1085–1097, March 20, 2009 ª2009 Elsevier Inc. 1089
Figure 4. Ste5-ms Domain Selectively Improves kcat, but Not KM, for the Substrate, Fus3
(A) Simple kinetic scheme for Ste7/MAPK phosphorylation. Ste7EE enzyme converts substrate (MAPK) into doubly-phosphorylated product (MAPK-pp). Fus3
and Kss1 phosphorylation by Ste7EE was quantified using in vitro western blots with an anti-phospho p44/42 MAPK antibody (see Figures S1A–S1D and S4).
(B) Michaelis-Menten plots show Fus3 phosphorylation requires Ste5-ms, Kss1 phosphorylation does not. Ste7EE-ND2 (which contains only one MAPK docking
motif, KD100nM), and Fus3-K42R (which is catalytically dead) were used to simplify the analyses. Kinase reactions contain 50nM Ste7EE-ND2, and a saturating
concentration (1000 nM, where appropriate) of Ste5-ms (see [E]). Fus3 activation by Ste7EE-ND2, in the absence Ste5-ms, is very slow but can be measured
(inset graph). Error bars show standard deviation of triplicate runs.
(C) Ste5-ms enhances the kcat of Ste7/Fus3 phosphorylation by5000-fold, with negligible effect on KM. Ste5-ms has little or no effect on the kcat or KM of Kss1
phosphorylation. Overall specificity (kcat /KM) of Ste7 for Fus3 and Kss1 is comparable (105 M-1 s-1).
(D) Effect of Ste5 on Ste7/MAPK phosphorylation reaction parameters, plotted as the fold-change in kcat, 1/KM, and kcat /KM for Fus3 and Kss1 activation by
Ste7EE-ND2. Major effect of Ste5 is enhancement of the kcat for Fus3 phosphorylation.
(E) Determination of the concentration of Ste5-ms required to drive Ste7/Fus3 phosphorylation. 50 nM Ste7EE was used along with a saturating amount of Fus3
(750 nM, based on [B]). Rate of Fus3 activation reaches half-maximum at 161nM Ste5-ms (±60nM), which we infer is an apparent dissociation constant for the
Ste7/Ste5-ms interaction. 1000 nM Ste5-ms, used in experiments described in panel 4B, represents a saturating concentration.
(F) Reaction free energy diagram illustrating how Ste5-ms selectively lowers the energy of the transition state for Fus3 phosphorylation (dotted line).eukaryotes appear to be intracellular proteins involved in diverse
multiprotein assemblies (Whittaker and Hynes, 2002).
Using the Ste5-ms structure as a guide, we performed exten-
sive mutagenesis of the ms domain surface to try to identify1090 Cell 136, 1085–1097, March 20, 2009 ª2009 Elsevier Inc.regions of the protein that are critical for catalysis (Figure S6).
Twenty one mutant proteins were generated, each containing
a block of 2–3 mutant residues clustered together on the protein
surface. Of these mutant proteins, six out of 21 showed greatly
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Figure 5. Ste5-ms Is a Folded Domain with Distinct Surfaces Important for Kinase-Binding and Catalysis
(A) Crystal structure of the Ste5-ms domain (1.6 A˚ resolution; data collection and refinement statistics can be found in Table S2). Structural figures were made
using Pymol (DeLano, 2002). Deposited as PDB ID 3FZE.
(B) Structural alignment using DALI illustrates the Ste5-ms domain is homologous to the von-Willebrand Type-A (VWA) domain. Cartoon of VWA domain fold and
topology.
(C) Ste5-ms has two distinct surfaces critical for Fus3 phosphorylation by Ste7 (identified by surface mutant scan of Ste5-ms for mutations with >100-fold
decrease in activity. See Figure S6 for full list of mutants used in the scanning experiment). One interface, the ‘‘coactivator loop’’ (745–756) is critical for catalyzing
Ste7/Fus3 phosphorylation (phenotypes are represented by mutant ‘‘C,’’ N744A/D746A), and another interface is necessary for Ste7-binding (represented by
mutant ‘‘B,’’ deletion of 778–786).
(D) kcat of Ste7/Fus3 phosphorylation reduced 100-fold for Ste5-ms mutant B and reduced nearly 1000-fold for mutant C. Error bars denote standard deviation
of three measurements. These mutants have no effect on the KM of Ste7-Fus3 phosphorylation (data not shown). Ste5-ms variants present at 1 mM, a concen-
tration that saturates binding to Ste7 for Ste5-ms wild-type.
(E) Pull-down assays show Ste5-ms mutant B is defective in binding to Ste7; mutant ‘‘C’’ maintains Ste7 binding. Ste5-ms mutants were expressed as fusions to
maltose binding protein (MBP) as a pull-down affinity tag.
(F) Catalysis of Ste7/ Fus3 reaction by Ste5-ms mutant B, but not mutant C, can be restored by adding much higher concentrations of the mutant scaffold
domain. Vmax for Ste7/Fus3 reaction, measured using 50 nM Ste7EE and 750 nM Fus3. Point of half-max activation (Kact) gives apparent dissociation
constants of Ste5-ms variants for Ste7. As expected, wild-type Ste5-ms has a Kact of 150 nM, while Mutant ‘‘B’’ had greatly diminished Kact = 15,500 nM, consis-
tent with a defect in Ste7 binding. At high enough concentrations, mutant B can promote signaling to near wild-type levels. Ste5-ms mutant C shows a Kact close
to wild-type (71 nM) (Figure S7B), but its Vmax at saturating concentrations is 1000-fold lower than wild-type (bar graph to right). This behavior is consistent with
a defect in the catalytic step of Ste7/Fus3 phosphorylation.Cell 136, 1085–1097, March 20, 2009 ª2009 Elsevier Inc. 1091
diminished (>100-fold decrease) ability to promote Ste7-to-Fus3
phosphorylation (Figure S6B). We then screened these mutants
for their effect on both binding to Ste7 and on the kcat of Fus3
phosphorylation (Figures S6B and S7A).
Five of the six mutations to the Ste5-ms domain that signifi-
cantly disrupt activity cluster on two structurally and functionally
distinct interfaces (Figure 5C). The first interface contains four
sets of mutations that selectively block catalysis without disrupt-
ing binding to Ste7; these mutations significantly reduce the kcat
for Ste7EE-ND2/Fus3 phosphorylation, but do not alter Ste7/
Ste5-ms interaction (representative mutant ‘‘C’’ is shown
in Figures 5D and 5E). This region is composed of a semi-disor-
dered loop (residues 745–756) which we have named the ‘‘coac-
tivator loop.’’ We postulate that this loop plays a role in lowering
the barrier of the Ste7/Fus3 phosphorylation reaction, perhaps
through transient interactions with Fus3.
A second interface, near the C terminus of the Ste5-ms
domain, appears to be involved in direct binding to Ste7. This
interface consists of a negatively charged segment (DEHDDD
DEEDN, residues 776–786). Mutant ‘‘B’’ is a variant of the
Ste5-ms domain in which the nine most C-terminal residues
(778–786) have been deleted. This mutant is catalytically
impaired, most likely because, as shown in pull-down assays,
it has greatly reduced binding to Ste7 (Figures 5D and 5E). In
summary, there appear to be two functionally distinct surfaces
on the Ste5-ms domain that are critical for its function in
promoting Ste7/Fus3 phosphorylation: one that is responsible
for association with Ste7, and a distinct surface that is respon-
sible for Fus3-specific catalysis.
A prediction of this model is that the mutations that selectively
reduce the affinity of the Ste5-Ste7 interaction should be able to
rescue the Ste7/Fus3 reaction if added at much higher
concentrations (kcat values shown in Figure 4D were only
measured at a concentration of 1 mM Ste5-ms). As predicted,
a Ste5-ms protein bearing mutation B, which selectively disrupts
Ste7 binding, has a kcat for the Ste7/Fus3 reaction that is
comparable to that of the wild-type protein, but only when added
at100-fold higher concentrations (Figure 5F). In contrast, addi-
tion of increasing amounts of a Ste5-ms protein bearing mutation
C (a ‘‘coactivator’’ mutation) plateaus at a kcat that is 1000-fold
lower than observed with wild-type Ste5-ms (does not result in
increased kcat) (Figure S7B).
The importance of these two regions within the Ste5-ms
domain is also highlighted by alignment of homologs of Ste5
from other fungal species. The most conserved region of these
Ste5 scaffold homologs corresponds to the Ste5-ms domains
(Figure S3B), and especially both within the coactivator loop
(745–756) and across the previously defined Ste7 binding region
(Figure S3C).
Ste5-ms Domain Catalytically Unlocks Fus3
for Phosphorylation by Ste7
There are two distinct models for how the Ste5-ms domain
promotes Ste7/ Fus3 phosphorylation. One model is that the
Ste5-ms primarily acts as an activator of Ste7 to enhance its
overall catalytic activity (Figure 6A, top), much as a cyclin acti-
vates a CDK. A second competing model is that Ste5-ms
primarily acts to convert Fus3 from a poor Ste7 substrate to1092 Cell 136, 1085–1097, March 20, 2009 ª2009 Elsevier Inc.a good Ste7 substrate (Figure 6A, bottom). A prediction of the
first model is that addition of Ste5 to Ste7 will enhance its overall
kinase activity toward any substrate. To test this model, we
compared rates of phosphorylation of a general substrate,
myelin basic protein, by Ste7EE, in the presence and absence
of the Ste5-ms domain (Figure 6B). The rates are indistinguish-
able, indicating that the Ste5-ms domain is not a general acti-
vator of Ste7. In addition, as described above, the addition of
Ste5-ms has no effect on the Ste7/Kss1 reaction (Figures 4B
and 4C). These two findings strongly disfavor a model where
the Ste5-ms upregulates the general kinase activity of Ste7 to
enhance Fus3 phosphorylation.
These results point toward the alternative model in which the
Ste5-ms exerts its effect on the substrate – it selectively improves
Fus3 as a substrate for Ste7. This model suggests that a key
difference between the closely related, competing MAPK’s
Kss1 and Fus3, is that Kss1 is already primed to be a good
substrate for Ste7, but that Fus3 is, by itself, locked in a state
that makes it a poor substrate. If this is true, then we reasoned
it might be possible to make mutations in Fus3 that ‘‘unlock’’ it,
making it more like Kss1 which can serve as a scaffold-indepen-
dent substrate for Ste7. We made ten sets of mutations in Fus3
that make the sequence more like Kss1, based on sequence
regions that diverge between Fus3 and Kss1. We tested the ability
of activated Ste7 (Ste7EE-ND2) to phosphorylate these chimeric
mutants in the absence of Ste5 (Figures S8A–S8D). We found that
a mutation of residue I161L combined with replacement of resi-
dues 243–254 (a region known as the ‘‘MAPK insertion loop’’)
with the comparable insert from Kss1 resulted in a Fus3 variant
that had an approximately 20-fold increase in kcat compared to
Fus3 wild-type, in the absence of scaffold (Figures 6C and
S8D). Consistent with this result, previous studies showed that
a I161L mutant in Fus3 could partially complement the loss of
Ste5 scaffold in mating pathway activation in vivo (Brill et al.,
1994). We mapped the location of mutations that ‘‘unlock’’ Fus3
onto its crystal structure (Reme´nyi et al., 2005), which shows
that these residues lie near the Fus3 activation loop (Figure 6D).
These data suggest a model for how Fus3 phosphorylation
may be regulated by the Ste5 scaffold. We postulate that
Fus3’s activation loop normally exists in a locked state so that
it cannot be easily phosphorylated by Ste7. However, when
the scaffold is present and bound to Ste7, the Ste5-ms domain
may stabilize a transition-state conformation of Fus3’s activation
loop that is accessible to Ste7 (Figure 6E). The precise mecha-
nism of how the activation loop structure and dynamics are
altered remains to be elucidated.
DISCUSSION
Assisted Catalysis and Tethering: Complementary
Mechanisms by which the Ste5 Scaffold Directs
Specificity of MAPK Signaling
Scaffold proteins have emerged as important elements in deter-
mining the wiring of cell signaling pathways. The simplest model
for how scaffolds direct signaling specificity is through tethering:
corecruiting components to the same site. In the case of the
yeast mating MAPK scaffold Ste5, there is ample evidence that
tethering plays a central role in its function: Ste5 interacts with
the Gb protein Ste4, the MAPKKK Ste11, and the MAPKK Ste7,
and disruption of these interactions is sufficient to destroy proper
signaling. Moreover, the effects of these mutations can be over-
come by re-recruiting the missing components to the complex
via heterologous interactions or protein fusions (Harris et al.,
2001; Park et al., 2003). Nonetheless, it has been far less clear
if Fus3 activation in the mating pathway is directed by Ste5
through a tethering mechanism, because disruption of the previ-
ously mapped Fus3 interaction site on Ste5 does not impair the
mating response (Bhattacharyya et al., 2006a).
Here we show that the Ste5 scaffold protein plays a far more
active, cocatalytic role in directing Ste7/Fus3 signaling. A
A
E
B
C
D
Figure 6. Ste5-ms Catalytically Unlocks Fus3 for Phosphorylation by Ste7
(A) Two potential models for how Ste5-ms enhances Ste7/Fus3 phosphorylation. One model proposes that Ste5-ms primarily acts on Ste7; Ste7 is a poor
enzyme that requires Ste5-ms binding to increase its activity (top). An alterative model hypothesizes that Ste5-ms acts primarily on Fus3 - converting it from
a poor substrate to a good one (bottom).
(B) Ste5-ms has no effect on overall catalytic activity of Ste7EE as tested against the general kinase substrate, Myelin Basic Protein (MBP) using a 32P kinase
assay.
(C) To identify elements in Fus3 that make it a poor substrate compared to Kss1, we made mutations in Fus3 that make it more similar in sequence to Kss1
(Figures S8A and S8B). These mutants were tested for their ability to be phosphorylated by Ste7EE in the absence of Ste5 (Figures S8C and S8D). A combined
mutation of I161L with replacement of the 243-254 ‘MAPK insertion loop’ (with the same region from Kss1) created a Fus3 mutant with a 20-fold increase in kcat
compared to wild-type (reaction contains 50 nM Ste7EE-ND2, 750 nM Fus3 variant, no scaffold). Error bars represent standard deviation from three data sets.
(D) Crystal structure of Fus3 (Remenyi et al., 2005), showing positions of critical mutations in red (I161L, and MAPK insert 243–254). The activation loop (shown as
dotted line; not fully visible in the crystal structure) sits between these two regions. Residues that become phosphorylated (T180 and Y182) shown in green.
(E) A model for Ste5-ms action: Fus3’s activation loop normally adopts a ‘‘locked’’ conformation, but Ste5-ms interaction with Fus3 transiently (and only in the
presence of Ste7) stabilizes a transition state in which Fus3’s activation loop is accessible to Ste7.Cell 136, 1085–1097, March 20, 2009 ª2009 Elsevier Inc. 1093
specific domain in Ste5, which we have named the minimal scaf-
fold, or ‘ms’ domain, is a necessary cofactor for the Ste7/Fus3
phosphorylation reaction: Fus3 is an extremely poor substrate in
the absence of this Ste5 domain, although Ste7 is a perfectly
competent enzyme. Conceptually, this domain of the scaffold
is a required cofactor, much like a cyclin is a required cofactor
for CDK. However, the Ste5-ms domain appears act in a unique
fashion: kinase accessory factors like a cyclin generally act by
either globally increasing the kcat for kinase activity (usually
by allosterically repositioning key catalytic residues) or by
decreasing the KM for specific substrates via additional
substrate recognition sites (Loog and Morgan, 2005; Pavletich,
1999). In this case, the Ste5 scaffold improves the kcat of the
phosphorylation reaction, but in a manner that is only specific
for one substrate, Fus3. The KM of Ste7/Fus3 phosphorylation
is likely dictated by the strength of MAPK docking interactions
(data not shown).
A catalytic role for the Ste5 scaffold helps to explain several
paradoxes concerning organizing factors like scaffolds that
were presumed to function solely by a tethering mechanism.
First, if a tethering scaffold is present at a higher concentration
than its components, it might cause inhibition of pathway, by
segregating individual components into different complexes.
Second, if a tethering scaffold uses increased binding energy
to shunt signaling specificity toward one substrate, then it may
be more difficult to release this component. This issue is critical
for a MAPK like Fus3, which must dissociate from the scaffold
and enter the nucleus to exert many of its downstream effects.
FRAP studies show that Fus3 rapidly dissociates from the Ste5
complex, more so than other pathway components (van Drogen
and Peter, 2002; van Drogen et al., 2001). These two issues,
however, are mitigated by a mechanism in which the scaffold
plays a direct catalytic role. Inhibitory segregation would not
be observed if the Ste7-Ste5 complex is the only unit that is
able to activate Fus3 (Ste7 or Ste5 cannot activate Fus3 individ-
ually). In addition, the lack of a strong direct Ste5-ms/Fus3 inter-
action in the Fus3 activation step may allow reasonably rapid
dissociation of active Fus3 from the complex (Maeder et al.,
2007).
A Revised Model for How Ste5 Coordinates the Mating
MAPK Pathway
While Ste5 still acts as a central organizer of the mating MAPK
pathway, our new findings force us to update the model of
how Ste5 directs the flow of information (Figure 7). Most signifi-
cantly, an updated model must include a role for the Ste5-ms
domain in cocatalyzing Fus3 phosphorylation by Ste7. It is also
now clear that there are both activating and downregulatory
interaction sites for Fus3 on the scaffold (Figures 7A and 7B).
Activation of the mating response requires recruitment of Fus3
to Ste7 docking motifs, and a transient, catalytic interaction
with Ste5-ms. Conversely, downregulation of pathway output
is mediated in part by recruitment of Fus3 to its strong binding
site on Ste5.
An updated model of the mating pathway is summarized
below. Binding of a-factor to its receptor (Ste2) leads to dissoci-
ation of the Gb protein (Ste4) from the Ga subunit (Gpa1).
Activated Ste4, which is membrane tethered, binds to Ste5,1094 Cell 136, 1085–1097, March 20, 2009 ª2009 Elsevier Inc.recruiting it to the membrane, allowing the membrane-localized
PAK kinase, Ste20, to phosphorylate and activate the MAPKKK
Ste11 (bound to Ste5). Phosphorylated Ste11 then activates
scaffold-associated MAPKK Ste7. We now understand that
Ste7, only when phosphorylated and bound to the Ste5-ms
domain can activate Fus3, since both Ste7 and the Ste5-ms
domain are required to work together catalytically to promote
Ste7/Fus3 phosphorylation. In support of this model, a muta-
tion (E756G) that maps to the coactivator loop of Ste5-ms was
previously shown to destroy the ability of Ste7 to activate Fus3
(but not Kss1) during the mating response, in vivo (Schwartz
and Madhani, 2006). In our model, Fus3 recruitment to the scaf-
fold complex is still important but is carried out via a docking
interaction with Ste7, not by binding to Ste5. These docking
motifs are one of several absolutely required elements for
Ste7/ Fus3 phosphorylation. After activation, Fus3 dissociates
from the Ste5 complex to enter the nucleus, where it can exert its
downstream effects.
While there is a strong (KD = 1 mM) binding site for Fus3 on Ste5
(residues 288–316), this site does not appear to play a significant
role in directing the main forward flow of signaling information
down the MAPKKK/MAPKK/MAPK cascade. Rather, this
site downregulates mating signaling—through feedback phos-
phorylation of Ste5 by Fus3—and thereby tunes the amplitude
and dynamics of pathway output (Bhattacharyya et al., 2006a).
Other studies have also suggested a role for this regulatory
Fus3-binding domain in tuning the precise input/output behavior
of the pathway: mutation of this domain leads to misregulation of
mating projection formation, and improper decision making
between budding, shmooing, and elongated growth cell fates
(Hao et al., 2008; Maeder et al., 2007).
Evolution of New Pathways: How the Ste5 Scaffold May
Have Facilitated the Functional Divergence of the Fus3
and Kss1 MAPKs
New signaling pathways are thought to emerge through duplica-
tion of signaling components, followed by their functional diver-
gence. This mechanism of evolution raises issues of specificity –
when components are duplicated, how is improper crosstalk
avoided, given that they will interact with the same upstream
and downstream partners? Based on their similarity, it seems
likely that Fus3 and Kss1 originated from just this type of dupli-
cation event. Although a simple tethering scaffold protein can
contribute to distinguishing the partners of such close homologs,
it seems unlikely that a shift in relative affinities would be suffi-
cient to completely prevent misactivation by the wrong upstream
pathway. In this case, it seems particularly important that acti-
vated Ste7 that results from starvation input (filamentous growth
pathway) does not lead to launching of the costly mating
response.
To avoid misactivation, it appears that Fus3 has evolved
a safety catch mechanism that distinguishes it from Kss1. We
postulate a model in which the activation loop of Fus3 is
‘‘locked,’’ making it a poor substrate for Ste7 alone. However,
this lock can be kinetically opened by the Ste5-ms domain.
Thus, as discussed previously by Flatauer et al., Fus3 can only
be phosphorylated by Ste7 that is activated and bound within
the Ste5 complex. Active Ste7 associated with Ste5 is likely to
BFigure 7. An Updated Model for How the Ste5 Scaffold Controls Information Flow in the Mating MAPK Pathway
(A) Ste5 has upregulatory (activating) and downregulatory interactions with Fus3. The strong, previously identified Fus3 binding site on Ste5 (Fus3-BD, KD = 1 mM)
is not required for Ste7/Fus3 phosphorylation, but rather is important for tuning down pathway output in vivo. Interactions that promote Fus3 phosphorylation
involve the Ste5-ms domain (in cooperation with Ste7).
(B) Cartoon summarizing various activities of Ste5. The Ste5-mediated complex has several critical tethering interactions (Ste5-Ste11, Ste5-Ste7, and Ste7-Fus3)
essential for linear propagation of the mating pathway signal. In addition, Ste5-ms domain is an essential cofactor promoting catalysis of the Ste7/Fus3 phos-
phorylation reaction.
(C) Detailed model of minimal interactions in the mating scaffold complex required for Ste7/Fus3 phosphorylation. Ste7 binds strongly to both Ste5-ms domain
(via surface on Ste5-ms colored blue) and Fus3 (docking motifs on Ste7 bind to docking groove on Fus3, colored gray), thereby tethering two proteins that nor-
mally interact only very weakly. Ste5-ms contains a coactivator loop (red surface) which promotes Fus3’s phosphorylation by Ste7. Fus3’s activation loop is
colored red. Interaction affinities, where known, are indicated. Interactions that modulate kcat and KM of Fus3 phosphorylation by Ste7 are indicated by black
boxes. Models for Fus3 (PDB code 2B9F) and Ste5-ms (this study) are derived from crystal structures. Ste7’s kinase domain was modeled from the structure
of a homologous mammalian MAPKK (MKK7) using the threading program Phyre (Bennett-Lovsey et al., 2008).only arise via activation by mating input. While it is formally
possible that Ste7 activated by starvation input could subse-
quently bind to Ste5, there is evidence that Ste5 may not be
competent for Fus3 activation in unstimulated cells. Ste5 trans-
locates to the membrane upon alpha-factor stimulation (not by
filamentation input) and it has been hypothesized that this trans-
location promotes a conformational change in Ste5 that is impor-
tant for mating pathway activation (Flatauer et al., 2005; Inouye
et al., 1997b; Sette et al., 2000). In support of this, a number of
mutations or fusions to Ste5 that enhance membrane localiza-
tion lead to increased mating signaling (Winters et al., 2005). It
is possible that Ste7 only binds to the scaffold, or that Ste5-ms
is only accessible for Ste7-Fus3 catalysis, when the Ste5 scaf-
fold is in the proper conformation at the membrane.Phylogenetic analysis of close fungal species supports this
general duplication-divergence model involving scaffold coca-
talysis (Figure S9). Within the subphylum Saccharomycotina,
the majority of genomes contain two homologs of the mamma-
lian ERK MAPK (the subfamily encompassing Fus3 and Kss1),
consistent with a duplication of this gene prior to this branch-
point. All ten fungi that contain a Ste5 sequence homolog fall
within this subphylum and have a Fus3/Kss1 (ERK) duplication.
This data is consistent with a model in which Ste5 was one solu-
tion for promoting the functional divergence of the duplicated
MAP kinases, Fus3 and Kss1. Other mechanisms to diverge
these kinases have also evolved: for example misactivation of
the filamentous response by mating input is blocked by Fus3-
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factor, Tec1 (Bao et al., 2004; Chou et al., 2004). Interestingly,
Tec1 is present only in the fungi that also have Ste5
(Figure S9). Species within Saccharomycotina that lack Ste5
and Tec1 presumably have alternative mechanisms to promote
functional divergence, perhaps yet undiscovered scaffolds. It
will be exciting to see if other pathway scaffold proteins,
including those involved in mammalian MAPK signaling (e.g.,
JIP, KSR, etc.) utilize a kind of direct catalytic assistance to
promote specific kinase-substrate reactions, and whether these
are associated with other evolutionary duplication-divergence
branchpoints.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
For expanded methods, see Supplemental Data. Fus3, Ste5 scaffold trunca-
tions, and Ste5-ms variants were expressed in Rosetta (DE3) pLysS E.coli
cells. Ste7 variants and Kss1 were expressed in Spodoptera frugiperda
(SF9) cells. Purification was carried out as described previously (Remenyi
et al., 2005), with some modifications (see Supplemental Data).
In Vitro Kinase Assays
Trulight Kinase Assay
The Ste7-to-MAPK phosphorylation reactions were measured in a continuous,
high-throughput fashion using the Trulight Superquenching Kinase Assay (Kit
#539710, EMD Biosciences) in 96-well plates on a SpectraMax Gemini XS
fluorescence plate-reader (Molecular Devices). Kinases and scaffold were
added at 50 nM concentration unless written otherwise. Trulight assay kit
includes proprietary sensor beads coated with a fluorescent polymer,
a MAPK-specific peptide (LVEPLTPSGEAPNQK) labeled with a Lissamine
Rhodamine B quencher, and Assay Buffer. Kinase activity (phosphorylation
of the peptide) is monitored as a loss in fluorescence over time. For more
details on the Trulight Assay, see Figures S2D–S2F.
Quantitative Anti-Phospho MAPK Western Blots
Quantitative in vitro western blots, used to monitor accumulation of pTyr/pThr
on the activation loop of either Fus3 or Kss1, were carried out using a primary
anti-phospho p44/42 MAPK antibody (Cell Signal Technology, #9101) which
recognizes both Fus3 and Kss1 equally (Figure S1D), and a secondary IRDye
800CW Goat Anti-Rabbit IgG antibody (Li-Cor, #926-32211). Kinase reactions
contained 50 nM enzyme (GST-Ste7EE or GST-Ste7EE-ND2) and 1 mM Ste5
scaffold, with varying concentration of substrate (either Fus3 or Kss1), unless
otherwise noted. Standard kinase assay buffer included 100 mM NaCl, 25 mM
Tris (pH 8), 0.05% NP-40 and 2 mM TCEP (plus 2 mM MgCl2 and 2 mM ATP).
Note, we varied the concentration of enzyme (10 nM and 250 nM Ste7EE-ND2)
to test if this could drastically alter the kcat and KM values for Fus3 phosphor-
ylation—it did not. Blots were visualized using the 800 nm channel on Li-Cor
Odyssey Imaging System and quantified using Odyssey 2.1 software (see
Figure S4 for further details). Rate plots for Fus3 and Kss1 phosphorylation
were fit to the Michaelis-Menten equation (V = k2[E][S]/(KM+[S]), using
nonlinear least-squares method in Matlab. The KM and kcat values were calcu-
lated as the average of fitting the Michaelis-Menten equation to three separate
curves (from three separate experiments), and errors reported as standard
deviation. Kact plots were fit to a simple binding equation (y = a1 + a2(([X]/
KD)/(1+([X]/KD)))), also in Matlab.
Radioactive Kinase Assay
Phosphorylation of the general kinase substrate, Myelin Basic Protein (Sigma),
by GST-Ste7EE was monitored by the rate of incorporation of 32P using auto-
radiography. Assay conditions included: 0.5 mM GST-Ste7EE, 2.5 mM Ste5-ms
(where present), and standard kinase assay buffer (listed above) plus 10 mM
32P-ATP, 500 mM cold ATP, and 1 mM MgCl2.
Protein Binding Assays
Fluorescence Polarization
Binding of GST-Ste7wt and Fus3 to fluoroscein-labeled Ste5-ms was moni-
tored using anisotropy. We removed a surface exposed Cysteine (residue1096 Cell 136, 1085–1097, March 20, 2009 ª2009 Elsevier Inc.724), and added a Lys-Cys-Lys motif to the N-terminus of Ste5-ms for malei-
mide-fluoroscein labeling. The modified protein is called ‘KCK-Ste5-ms’. Inter-
action with 5nM KCK-Ste5ms was measured in standard buffer (plus 3 mM
Maltose Binding protein and cell lysate, to stabilize proteins and reduce
non-specific interactions) using 384-well Corning plates on a Molecular
Dynamics Analyst AD (ex. filter 485 nm, em. filter 530 nm). Curves were fit to
a simple binding equation (y = a1 + a2(([X]/KD)/(1+([X]/KD)))), in Matlab.
Pull-Down Binding Assays
10 mg of MBP-Ste5-ms was incubated with 10 mg of GST-Ste7 for 20 min and
then added to 15 uL of Amylose resin (NEB) for 1 hr at 4C. Beads were washed
(using 100 mM NaCl, 25 mM Tris [pH 8], 10% Glycerol, 0.1% IGEPAL, 2mM
DTT) and protein was eluted with 23 SDS-loading dye and boiling.
Structure Determination
Crystals of Ste5-ms were obtained by mixing 10 mg/mL of protein (1:1 vol:vol)
with a solution containing 20% PEG 3350, 0.1 M citrate (pH 5.8), in hanging
drops at room temperature. Crystals were visible within two days and grew
to a maximum size of 0.5 mm. Native crystals, in cryopreservant, diffracted
to 1.6 A˚ at BL8.3.1 at the Advanced Light Source at LBNL. Phases were
derived experimentally from crystals soaked in a 10 mM HgCl2 solution (20%
PEG3350, 0.1 M citrate [pH 5.8]) for 30 min. Methods for data processing
and refinement can be found in the Supplemental Experimental Procedures.
X-ray diffraction data and refinement statistics are shown in Table S2.
ACCESSION NUMBERS
The Ste5-ms structure has been deposited in the Protein Data Bank under the
ID code 3FZE.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, nine
figures, two tables, and Supplemental References and can be found with
this article online at http://www.cell.com/supplemental/S0092-8674(09)
00134-2.
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